FIND DOCTORS
-
Name: Wang,Jialei
Department: MEDICAL ONCOLOGY
Title:Associate ProfessorEducation & Professional Experience
2009- Associate Professor, Department of Medical Oncology, Fudan University, Shanghai Cancer Hospital.
2007-2008 Sister Institution Associate, Dept. of Lymphoma & Myeloma, University of Texas, The M.D.Anderson Cancer Center, Houston, Texas, 77030，USA
2003-2009 Attending Physician, Department of Medical Oncology, Fudan University, Shanghai Cancer Hospital.
2000-2003 Master of Science, Department of Medical Oncology, Fudan University, Shanghai Cancer Hospital.
1997-2003 Resident, Department of Medical Oncology, Fudan University, Shanghai Cancer Hospital.
1992-1997 Bachelor of Medicine, Clinical Medicine, Shanghai Medical University
Specialty Lung cancer, esophageal cancer, thoracic Oncology Research Lung cancer, esophageal cancer Publication 1.Wang JL, Hong XN, Tang WY, et al: Experience of gemcitabine plus cisplatin chemotherapy in 52 patients with head and neck cancer. Chinese Journal of Oncology 2005;27(9):567-569
2.Wang JL, Hong XN, Yin JL,et al: Effects of liposomal paclitaxel and paclitaxel in treatment of non-small—cell lung cancer(64 patients) and breast cancer (62 patients). Chinese Journal of New Drugs and Clinical Remedies 2006;25(1):1-4
3.Wang JL, Cao JN, Hong XN, et al: Clinical analysis of 32 cases with primary malignant germ cell tumors of mediastinum. Tumor 2007;27(10):829-831
4.Wang J, Li J, Hong X, et al: Retrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma. Oral Oncol 2008;44:464-470
5.Lin Y, Guo XM, Shen KW, Wang JL, Jiang GL: Primary breast lymphoma: Long-term treatment outcomeand prognosis. Leuk Lymphoma 2006;47 (10):2102-9
6.Cao JN, Yin JL, Wang JL, Hu XC, Zhu XD, Hong XN: Clinical study of Fludarabine-based combination chemotherapy for non-Hodgkin lymphoma patients. China Oncology 2006;16(7):575-577
7.Wang J, Li J, Qin S, et al: Randomized multicenter phase III trial of oxaliplatin plus raltitrexed compared to oxaliplatin plus fluorouracil and leucovorin treatment in recurrent and metastatic colorectal cancer. J Clin Oncol 2007;25(18s):abstr 4102(poster)
8.Wang M, Giralt S, Handy B, Feng L, Delasalle K, Wang J, Alexanian R. Complete remission predicts long survival in multiple myeloma. J Clin Oncol 2008;26 (15s):abstr 8523(oral presentation)
9.Wang J. Management of anti-cancer agents’ toxicities. Strategies of Diagnosis and Management in Medical Oncology. Li J. Shanghai Science and Technology Press. Pp232-247, 2007
10.Wang J, Sun Z, Hong X. Chapter 8: Introduction of Oncology. Cheng H, Lin G. Practice of Internal Medicine. People’s Hygiene Press (13th edition). Pp:166-205,2009
Awards 1.Outstanding Resident Award, Cancer Hospital, Fudan University, Shanghai, 2002-2003
2.Experience of gemcitabine plus cisplatin chemotherapy in 52 patients with head and neck cancer. Excellent Article Award, Class 2, Chinese Medical Association, Shanghai Branch, 2005
3.Randomized multicenter phase III trial of oxaliplatin plus raltitrexed compared to oxaliplatin plus fluorouracil and leucovorin treatment in recurrent and metastatic colorectal cancer. Excellent Article Award, Class 2, Chinese Society of Clinical Oncology, 2007 annual meetingOut-patient Schedule Monday afternoon
